<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kunz M</submitter><funding>Projekt DEAL</funding><funding>Wilhelm Sander-Stiftung</funding><funding>Wilhelm Sander-Stiftung (DE)</funding><pagination>173</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7685669</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>MiRNAs act as negative regulators of gene expression through target mRNA degradation or inhibition of its translation. In cancer, several miRNAs are upregulated and play crucial roles in tumorigenesis, making the inhibition of these oncomiRs an interesting therapeutic approach. This can be achieved by directly complementary single-stranded anti-miRNA oligonucleotides (antimiRs). A major bottleneck in antimiR therapy, however, is their efficient delivery. The nanoparticle formation with polyethylenimine (PEI) may be particularly promising, based on the PEI's ability to electrostatically interact with oligonucleotides. This leads to their protection and supports delivery. In the present study, we explore for the first time PEI for antimiR formulation and delivery. We use t</pubmed_abstract><journal>Journal of nanobiotechnology</journal><pubmed_title>Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.</pubmed_title><pmcid>PMC7685669</pmcid><funding_grant_id>2015.171.1</funding_grant_id><funding_grant_id>2015.191.1</funding_grant_id><pubmed_authors>Kunz M</pubmed_authors><pubmed_authors>Brandl M</pubmed_authors><pubmed_authors>Aigner A</pubmed_authors><pubmed_authors>Weigelt K</pubmed_authors><pubmed_authors>Kalwa H</pubmed_authors><pubmed_authors>Taubert H</pubmed_authors><pubmed_authors>Guzman J</pubmed_authors><pubmed_authors>Bhattacharya A</pubmed_authors><pubmed_authors>Ewe A</pubmed_authors><pubmed_authors>Nobereit-Siegel L</pubmed_authors><pubmed_authors>Weirauch U</pubmed_authors><pubmed_authors>Wach S</pubmed_authors><pubmed_authors>Reinert A</pubmed_authors><pubmed_authors>Hering D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.</name><description>&lt;h4>Background&lt;/h4>MiRNAs act as negative regulators of gene expression through target mRNA degradation or inhibition of its translation. In cancer, several miRNAs are upregulated and play crucial roles in tumorigenesis, making the inhibition of these oncomiRs an interesting therapeutic approach. This can be achieved by directly complementary single-stranded anti-miRNA oligonucleotides (antimiRs). A major bottleneck in antimiR therapy, however, is their efficient delivery. The nanoparticle formation with polyethylenimine (PEI) may be particularly promising, based on the PEI's ability to electrostatically interact with oligonucleotides. This leads to their protection and supports delivery. In the present study, we explore for the first time PEI for antimiR formulation and delivery. We use t</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Nov</publication><modification>2026-04-30T08:13:33.745Z</modification><creation>2026-04-07T15:56:44.889Z</creation></dates><accession>S-EPMC7685669</accession><cross_references><pubmed>33228711</pubmed><doi>10.1186/s12951-020-00728-w</doi></cross_references></HashMap>